Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Sarcoma 1Other 1Lymphoid 1

Conditions

Sarcoma 76Gastrointestinal Stromal Tumors 36Dendritic Cell Sarcoma, Interdigitating 22Glioblastoma 20Liposarcoma 19Gliosarcoma 19Neoplasms 18Leiomyosarcoma 16Bone Neoplasms 16Rhabdomyosarcoma 15Neoplasm Metastasis 15Lymphoma, Large B-Cell, Diffuse 15Burkitt Lymphoma 15Central Nervous System Neoplasms 14Sarcoma, Synovial 13Recurrence 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Osteosarcoma 13Hemangiosarcoma 12Fibrosarcoma 12Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myeloid, Acute 11Leukemia, Myeloid, Accelerated Phase 11

Interventions

pegfilgrastim 1Vincristine 1Rituximab 1Prednisolone 1Lenalidomide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Heart Failure × Sarcoma × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡